Evidence map›Paper›PMID 41965830›Full record

ArticleEMBO reports2026

Combinatorial effects of multiple genes contribute to beneficial aneuploidy phenotypes.

M Sophie Koller, Claudia Himmelbauer, Sarah Fink, Madhwesh C Ravichandran, Christopher S Campbell

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M Sophie KollerMax Perutz Labs, Vienna Biocenter, Vienna, Austria.
Claudia HimmelbauerMax Perutz Labs, Vienna Biocenter, Vienna, Austria.
Sarah FinkMax Perutz Labs, Vienna Biocenter, Vienna, Austria.
Madhwesh C RavichandranMax Perutz Labs, Vienna Biocenter, Vienna, Austria.
Christopher S CampbellMax Perutz Labs, Vienna Biocenter, Vienna, Austria. christopher.campbell@univie.ac.at.ORCID 0000-0002-3927-344X

Funding

Austrian Science Fund (FWF) F 8802-B
6 · The paper itself

Abstract

Aneuploidy is one of the most common adaptive mechanisms to environmental selection in cells, yet its advantages over other genomic alterations remain unclear. We used budding yeast to determine if beneficial aneuploidy phenotypes are driven primarily by combinatorial expression changes of multiple genes. To determine the impact of complex aneuploidy on cellular fitness and drug resistance, we generated yeast collections with nearly every combination of two chromosome gains or losses. Additionally, we genetically dissected aneuploid chromosomes using partial deletions to identify chromosomal regions contributing to aneuploidy-driven drug resistance. Strong resistance phenotypes consistently came from combinations of chromosomes or chromosomal regions, with up to five regions on a chromosome contributing to resistance to a single drug. Gene ontology terms had limited predictive power in identifying the genes contributing to resistance phenotypes, as the combinatorial effects from different aneuploid regions act through multiple resistance pathways. The strongest phenotypes came from synergistic effects between copy number changes of different chromosomes or chromosomal regions, demonstrating how subtle gene expression changes of many genes combine to greatly impact cell survival.

Indexed as

AneuploidySaccharomyces cerevisiaeChromosomes, FungalDrug Resistance, FungalGene Expression Regulation, FungalPhenotype

Identifiers

PMID41965830
PMCPMC13219433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.